Back to today’s briefing

Story perspectives

Americans Turn to Microdosing Ozempic for Weight Loss

1/24/2025

44 8

Summary

Story summary

In the U.S., a rising trend has emerged as individuals turn to microdosing Ozempic, a diabetes drug, for weight loss. With 70% of American adults facing obesity or overweight issues, many are seeking cost-effective solutions. Dr. Christopher McGowan highlights that patients are opting for smaller doses to reap the medication's benefits while cutting expenses.

1 of 1

Story summary

In the U.S., a rising trend has emerged as individuals turn to microdosing Ozempic, a diabetes drug, for weight loss. With 70% of American adults facing obesity or overweight issues, many are seeking cost-effective solutions. Dr. Christopher McGowan highlights that patients are opting for smaller doses to reap the medication's benefits while cutting expenses.